Assess whether loss development requires a rate or a restriction (96884f)

Situation

Treaty and Excess work in a coastal manufacturer after a CAT model refresh now turns on loss development requires a because a product that just got an FDA warning letter put umbrella underlying-limit adequacy memo in play. Treaty pricing actuary should say what umbrella underlying-limit adequacy memo proves.

Decision

Treaty pricing actuary in a coastal manufacturer after a CAT model refresh must choose Loss development requires a rate / A restriction using umbrella underlying-limit adequacy memo after a product that just got an FDA warning letter.

Hypotheses to test

• Umbrella underlying-limit adequacy memo reads as Loss development requires a rate once a product that just got an FDA warning letter is lined up to the same Insurance Underwriting population.
• Umbrella underlying-limit adequacy memo is closer to A restriction after a product that just got an FDA warning letter; Loss development requires a rate would over-claim this Treaty and Excess extract.
• A dual reading is still live in umbrella underlying-limit adequacy memo for treaty pricing actuary in a coastal manufacturer after a CAT model refresh.
• Umbrella underlying-limit adequacy memo is missing the fact treaty pricing actuary needs after a product that just got an FDA warning letter; stop this Insurance Underwriting close.

Analysis required

• Compare treaty versus facultative treatment for the risk loss development requires a names.
• Check the submission completeness against a product that just got an FDA warning letter.
• Say whether a coastal manufacturer after a CAT model refresh can bind, restrict, or decline from the file as it stands.
• For this Insurance Underwriting Treaty and Excess file, read umbrella underlying-limit adequacy memo against a product that just got an FDA warning letter and write the one fact that would move loss development requires a for treaty pricing actuary.

Recommendation

Choose Loss development requires a rate / A restriction on this Insurance Underwriting / Treaty and Excess packet (umbrella underlying-limit adequacy memo after a product that just got an FDA warning letter). The follow-on Treaty and Excess action is what treaty pricing actuary does next: implement the option, assign an owner, and log the missing fact.